BDBM202307 US9540357, example 10::US9540357, example 9

SMILES: Cc1cc(O)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O

InChI Key: InChIKey=MZVULTSGLZNJIJ-NPJFLTDFSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 202307   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Prostaglandin E2 receptor EP4 subtype (Homo sapiens (Human))	BDBM202307 (US9540357, example 10 | US9540357, example 9) Show SMILES Cc1cc(O)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H31NO5/c1-20-18-26(32)13-14-27(20)23-5-2-6-24(19-23)28(33)15-11-25-12-16-29(34)31(25)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-11,13-15,18-19,25,28,32-33H,3-4,12,16-17H2,1H3,(H,35,36)/b15-11+/t25-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	25	-10.4	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair
Prostaglandin E2 receptor EP4 subtype (Homo sapiens (Human))	BDBM202307 (US9540357, example 10 | US9540357, example 9) Show SMILES Cc1cc(O)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H31NO5/c1-20-18-26(32)13-14-27(20)23-5-2-6-24(19-23)28(33)15-11-25-12-16-29(34)31(25)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-11,13-15,18-19,25,28,32-33H,3-4,12,16-17H2,1H3,(H,35,36)/b15-11+/t25-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3.32E+3	-7.47	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair
Prostaglandin E2 receptor EP2 subtype (Homo sapiens (Human))	BDBM202307 (US9540357, example 10 | US9540357, example 9) Show SMILES Cc1cc(O)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H31NO5/c1-20-18-26(32)13-14-27(20)23-5-2-6-24(19-23)28(33)15-11-25-12-16-29(34)31(25)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-11,13-15,18-19,25,28,32-33H,3-4,12,16-17H2,1H3,(H,35,36)/b15-11+/t25-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+4	>-6.82	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair
Prostaglandin E2 receptor EP2 subtype (Homo sapiens (Human))	BDBM202307 (US9540357, example 10 | US9540357, example 9) Show SMILES Cc1cc(O)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCc1ccc(cc1)C(O)=O |r| Show InChI InChI=1S/C30H31NO5/c1-20-18-26(32)13-14-27(20)23-5-2-6-24(19-23)28(33)15-11-25-12-16-29(34)31(25)17-3-4-21-7-9-22(10-8-21)30(35)36/h2,5-11,13-15,18-19,25,28,32-33H,3-4,12,16-17H2,1H3,(H,35,36)/b15-11+/t25-,28?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.00E+4	>-6.82	n/a	n/a	n/a	n/a	n/a	7.4	25
Allergan, Inc. US Patent					Assay Description A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...				US Patent US9540357 (2017) BindingDB Entry DOI: 10.7270/Q24M92QQ
					More data for this Ligand-Target Pair